cnrsvxz
But critically examining whether access to facebook is even close to the optimal way to go about this is extremely important. Zuckerberg gains a huge amount of power once the majority of the world is using his service -- and this power is of a type and scope that we've never encountered before in human history. There is zero doubt that he knows this, and we're kidding ourselves by ignoring his motivations and only focusing on what appear to be the immediate benefits.
We also cannot conflate the actual service being provided with our previous decades of experience of a free and neutral internet. We don't really know what dynamics we're foisting on the rest of the world with a project like this, so it's pretty important that we engage in discussions with the actual people that it would effect.
Take, for instance, the fact that there are a few mesh networks being set up in Africa. Do the people implementing and communicating over these networks want Zuck's facebook-internet? Have we asked? Have we considered that a conversation with those people would lend us a perspective that's basically mandatory if are to believe that we're actually being charitable rather than just making ourselves feel charitable?
This is dangerous territory we're moving into, both ethically and strategically. We're setting up power structures that we may never be able to deconstruct.
[0] http://opensourceecology.org/wiki/Global_Village_Constructio...
I neglected to mention precisely how I acquired it because, as mentioned, Neuralstem is not joking around. (It wasn't as a group buy.) They do not have any existing treatments on the market and currently have just two in human trials: NSI-189, an antidepressant and ostensibly nootropic, and NSI-566, a stem cell treatment for ALS. It's not surprising that they're freaked out by use of one of these treatments years before it could ever be approved as a pharmaceutical.
On another note, this summer I experimented with NSI-189[1] for depression to great effect. It's a hippocampal neurogenic agent currently prepping for phase 2 trials. I found that its antidepressant effects over a one-month cycle were remarkably similar to my single psilocybin experience a few years back. Specifically, they both (or rather, I) exhibited two characteristics:
(a) "Illuminating" rather than the "dulling" of traditional antidepressants. A feeling of irrational filters being lifted from all my senses and the cognitive functions directly adjacent to them. It doesn't feel like a band-aid like tricyclics and SSRIs do. It feels like a realization that the depression is a lie, that it doesn't reflect the actual state of the world.
(b) Persistence of the effect long after the chemical was no longer in my system. Where "long" was approximately two years for the psilocybin, and I'm coming up on four months after cessation of the NSI-189 with not just steady benefits but continuous improvement. This matches the results found in the Phase 1b trial.[2]
Now I haven't gotten an MRI to see if my hippocampus has grown to an abnormal size, like was found in an early mouse study, but my experience has made me extremely optimistic for the next ten years of antidepressant research. I'm fairly certain we'll be able to narrow down the exact mechanisms by which psychedelics alleviate depression and isolate them from the permanent destructive potential of most psychedelics.[3]
[0] http://www.longecity.org/forum/forum/169-brain-health/
[1] It is currently not being sold, and its patent-holder Neuralstem is being quite threatening toward would-be vendors. There is nothing illegal about purchasing it, but it would be difficult for anyone in the US without indirect access to a quality Asian synth lab and a domestic third party testing facility.
[2] http://smithonstocks.com/neuralstem-phase-1b-results-for-nsi...
[3] I should mention that though I'm comparing NSI-189 to traditional psychedelics in this comment, it doesn't actually have any major immediate effects. Common anecdotal effects include heightened taste and smell, back-of-skull pressure/ache and mild parasthesia. A couple instances of major, painful parasthesia in individuals with previous nerve damage. But no headspace, no high, no rush, no immediate feeling that you're taking a drug at all, and the antidepressant effects do not reveal themselves for at least a week.
The claim "people who are mean (by the YC partners' standards) to the YC partners or in their presence are unlikely to succeed in YC or the scene which has emerged around it" is a bit more reasonable.
It's not so much that pg has tunnel vision as it is that every founder has tunnel vision for YC's money and the smart ones structure their interactions with the moneyholders appropriately.